Skip to content
Open access

Plasma GFAP modifies the association of depressive symptoms with cognitive function: A population‐based study

Aug 2026 · Alzheimer's & Dementia · Vol 22 · 0 citations · 45 references
Medicine

Abstract

Late‐life depression is associated with cognitive impairment, but the underlying neural basis remains to be elucidated. We investigated the role of Alzheimer's disease (AD)–related plasma biomarkers in the depression–cognition association.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.